patents

Some pharmas acting like “toilet roll profiteers” on COVID-19, says clinician
Some pharmas acting like “toilet roll profiteers” on COVID-19, says clinician
Pharmaforum
transparency
COVID-19
pandemic
patents
artificial intelligence
Flag link:
Motion denied: Gilead still on the hook for $1.5B in damages over CAR-T patent dispute with Bristol Myers Squibb
Motion denied: Gilead still on the hook for $1.5B in damages over CAR-T patent dispute with Bristol Myers Squibb
Endpoints
Gilead Sciences
CAR-T
Bristol-Meyers Squibb
Juno Therapeutics
patents
Flag link:
Disaster at Amarin: Stock plummets 70% after Vascepa patent challenge loss
Disaster at Amarin: Stock plummets 70% after Vascepa patent challenge loss
Fierce Pharma
Amarin
Vascepa
generics
patents
Flag link:
AbbVie gives up patent rights to HIV med Kaletra amid COVID-19 tests: report
AbbVie gives up patent rights to HIV med Kaletra amid COVID-19 tests: report
Fierce Pharma
AbbVie
HIV
Kaletra
patents
COVID-19
Flag link:
Gilead loses again in PrEP patent fight with HHS, sending dispute to federal court
Gilead loses again in PrEP patent fight with HHS, sending dispute to federal court
Fierce Pharma
Gilead Sciences
PrEP
HHS
patents
HIV
Flag link:
Court Finds Sanofi Improperly Listed Insulin Device Patent in FDA’s Orange Book
Court Finds Sanofi Improperly Listed Insulin Device Patent in FDA’s Orange Book
RAPS.org
Sanofi
FDA
patents
insulin
Orange Book
Flag link:
Chinese firm copycats Gilead's remdesivir, the most promising drug against the new coronavirus
Chinese firm copycats Gilead's remdesivir, the most promising drug against the new coronavirus
Fierce Pharma
China
coronavirus
COVID-19
remdesivir
Gilead Sciences
patents
BrightGene
Flag link:
Will Biogen’s Big Patent Victory Ease Investor Worries About Its Alzheimer’s Drug?
Will Biogen’s Big Patent Victory Ease Investor Worries About Its Alzheimer’s Drug?
Motley Fool
Biogen
Mylan
Alzheimer's disease
patents
Tecfidera
MS
multiple sclerosis
Vumerity
Flag link:
AbbVie touts Humira defense strategy abroad as a positive sign for forthcoming U.S. battle
AbbVie touts Humira defense strategy abroad as a positive sign for forthcoming U.S. battle
Fierce Pharma
AbbVie
Humira
generics
patents
Flag link:
Gilead loses first PrEP patent challenge but vows to defend against HHS lawsuit
Gilead loses first PrEP patent challenge but vows to defend against HHS lawsuit
Fierce Pharma
Gilead Sciences
HHS
HIV
patents
PrEP
Truvada
Flag link:
Biogen wins Tecfidera patent challenge from Mylan, sending shares way up
Biogen wins Tecfidera patent challenge from Mylan, sending shares way up
Fierce Pharma
Biogen
patents
Tecfidera
Mylan
multiple sclerosis
MS
Flag link:
Wuhan Institute asks for patent on Gilead’s potential coronavirus drug
Wuhan Institute asks for patent on Gilead’s potential coronavirus drug
Pharmaforum
China
Gilead Sciences
patents
Wuhan Coronavirus
remdesivir
Flag link:
Fighting for market share, J&J expects last year's copycat pain to 'bleed into 2020'
Fighting for market share, J&J expects last year's copycat pain to 'bleed into 2020'
Fierce Pharma
JNJ
biosimilars
Velcade
Zytiga
patents
Flag link:
Apple Sued for Patent Infringement by Masimo and Affiliate
Apple Sued for Patent Infringement by Masimo and Affiliate
Motley Fool
Apple
Apple Watch
wearables
Cercacor
Masimo
patents
Flag link:
Lilly claims another victory in Alimta patent defence
Lilly claims another victory in Alimta patent defence
Pharmaforum
Eli Lilly
Alimta
patents
generics
Flag link:
The effect of patent expiration on sales of branded competitor drugs in a therapeutic class
The effect of patent expiration on sales of branded competitor drugs in a therapeutic class
Drug Patent Watch
patents
patent expirations
competition
Flag link:
Bristol-Myers Placed A Big Bet On Celgene’s Pipeline. Will It Pay Off For Investors?
Bristol-Myers Placed A Big Bet On Celgene’s Pipeline. Will It Pay Off For Investors?
Motley Fool
Bristol-Myers Squibb
Celgene
M&A
Revlimid
patents
Flag link:
Bristol-Myers wins $752 million in U.S. patent case against Gilead
Bristol-Myers wins $752 million in U.S. patent case against Gilead
Reuters
Bristol-Myers Squibb
Gilead Sciences
Kite Pharma
patents
Juno Therapeutics
Flag link:
Activists seek to block a Gilead patent extension on a lucrative HIV drug
Activists seek to block a Gilead patent extension on a lucrative HIV drug
Stat
Gilead Sciences
patents
HIV
activists
TAF
Flag link:
Will sky-high drug prices spur the US to use an obscure power over patents?
Will sky-high drug prices spur the US to use an obscure power over patents?
Biopharma Dive
drug pricing
patents
NIH
Flag link:

Pages